Literature DB >> 7002675

Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus.

M Neufeld, N K Maclaren, W J Riley, D Lezotte, J V McLaughlin, J Silverstein, A L Rosenbloom.   

Abstract

Islet cell antibodies (ICA) were detected in 168 (33%) of 504 patients with insulin-dependent diabetes mellitus (IDDM). Mean age of onset of IDDM was 8.6 +/- 0.2 yr and mean age at testing was 13.4 +/- 0.3 yr. None of 162 controls without diabetes (mean age 21.8 +/- 0.9 yr) had ICA. Caucasian patients (404) had a 74% frequency of ICA within 3 mo of diagnosis and an overall ICA frequency of 36%. These results were similar to those reported from Europe. Black patients (100) had lower frequencies of ICA (P < 0.01) and thyroid antibodies (P < 0.05). Caucasian patients with onset of IDDM before 5 yr of age (107) had a lower frequency (P < 0.01) of ICA (21%) than those (297) with a later age of onset (42%). Patients with persistent ICA beyond 5 yr of IDDM had increased frequencies of gastric parietal and adrenal cortex cell antibodies. Thyroid microsomal antibodies were less frequent (P < 0.05) in blacks (4%) than in Caucasians (20%). The former did not have adrenal antibodies. Similar ICA frequencies among Caucasians with IDDM in the U.S. and in Europe suggest that etiologic factors are similar in the two geographic regions. The lower frequencies of ICA in patients with IDDM onset before 5 yr of age suggest that some of these patients may have a different etiology and/or a more rapid disappearance of islet cell antigens than patients with a later onset.l The lower ICA frequencies in black patients can be explained by heterogeneity of IDDM in this group and by admixture of IDDM susceptibility genes from the Caucasian genome to the black genome.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002675     DOI: 10.2337/diab.29.8.589

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

Review 1.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 2.  Polyglandular autoimmune syndrome: current concepts.

Authors:  J Meyerson; E E Lechuga-Gomez; P E Bigazzi; P G Walfish
Journal:  CMAJ       Date:  1988-04-01       Impact factor: 8.262

3.  Polyglandular autoimmune syndrome type II.

Authors:  E E Lechuga-Gomez; J Meyerson; P E Bigazzi; P G Walfish
Journal:  CMAJ       Date:  1988-04-01       Impact factor: 8.262

4.  Italian Association of Clinical Endocrinologists (AME) & Italian Association of Clinical Diabetologists (AMD) Position Statement : Diabetes mellitus and thyroid disorders: recommendations for clinical practice.

Authors:  Edoardo Guastamacchia; Vincenzo Triggiani; Alberto Aglialoro; Antimo Aiello; Lucia Ianni; Mauro Maccario; Michele Zini; Carlo Giorda; Rinaldo Guglielmi; Corrado Betterle; Roberto Attanasio; Giorgio Borretta; Piernicola Garofalo; Enrico Papini; Roberto Castello; Antonio Ceriello
Journal:  Endocrine       Date:  2014-11-18       Impact factor: 3.633

5.  Auto-immunity in children with diabetes mellitus and in their relatives.

Authors:  R Lorini; D Larizza; C Livieri; V Cammareri; A Martini; A Plebani; D Zanaboni; F Severi
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

6.  Diagnostic approach to goitre in children.

Authors:  S Muirhead
Journal:  Paediatr Child Health       Date:  2001-04       Impact factor: 2.253

7.  Islet cell antibodies in the Japanese population and subjects with type 1 (insulin-dependent) diabetes.

Authors:  K Notsu; N Oka; S Note; N Nabeya; S Kuno; T Sakurami
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

8.  Type 1 (insulin-dependent) diabetes in Japanese children is not a uniform disease.

Authors:  T Urakami; Y Miyamoto; H Fujita; T Kitagawa
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

9.  A new method of detection of islet cell antibodies (ICA) using peroxidase-labeled protein A, and incidence of ICA in type 1 (insulin-dependent) diabetes.

Authors:  A Takahashi; M Tsujihata; A Yokota; Y Yamaguchi; Y Ueda; S Akazawa; S Miyake; S Nagataki
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

10.  Human leukocyte interferon treatment of two children with insulin dependent diabetes.

Authors:  K H Rand; A L Rosenbloom; N K Maclaren; J H Silverstein; W J Riley; B E Butterworth; J W Yoon; A H Rubenstein; T C Merigan
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.